The purchase of Paratek Pharmaceuticals in 2023 was Novo Holdings’ biggest solitary financial investment to day in therapies for antimicrobial resistance. Currently, the fund has actually marketed its risk.
发布者:BY ALBERT RONNING-ANDERSSON,转转请注明出处:https://robotalks.cn/three-years-after-major-acquisition-novo-owner-sells-stake-in-paratek/